News & Publications

Breakthroughs in Cancer Immunotherapy Webinar: Dr. George Coukos, Developing Effective Immunotherapy for Ovarian Cancer and Other Tumors

On June 17, 2014, George Coukos, M.D., Ph.D., director of the department of oncology at the CHUV, director of the service of developmental therapeutics, and the director of the Ludwig Centre at Lausanne, discussed how current immunotherapy treatment options for women with gynecologic cancers, and how close we are to making these treatments available to more patients.

This 45-minute online webinar, which is part of the Cancer Research Institute's Breakthroughs in Cancer Immunotherapy webinar series, was generously supported by Agenus.

Prior to his current roles, Dr. Coukos was the Celso Ramon Garcia Professor and Associate Chief of the Division of Gynecologic Oncology, and Director, Ovarian Cancer Research Center, at the University of Pennsylvania Abramson Cancer Center. He is a recognized global leader in ovarian cancer immunotherapy and tumor microenvironment research. His research focuses on understanding the immune system's response to ovarian cancer and other tumor types, and on developing therapies that enhance that response. He is also developing tools to target the tumor vasculature. Dr. Coukos also has extensive experience in designing and conducting phase I clinical cell-based immunotherapy studies, and in the development of cell-based immunotherapy from the laboratory to the clinic.